RenyLab promotes mass employee testing.
RenyLab In Vitro Diagnostics, Chemical and Pharmaceutical Industry of Barbacena-MG, carried out massive tests of its employees for Covid-19 between 07 and 08 July 2020. The test was carried out through rapid serological tests, with the aim of prioritizing the well-being and safety of employees, as well as contributing to the control of pandemic rates in Barbacena and region. All employees were tested and 100% of the results were negative for the new coronavirus.
According to the Ministry of Health, the state of Minas Gerais has the lowest incidence rate of the disease among all Brazilian states. On July 10, 2020, the state had 302.5 confirmed cases per 100,000 inhabitants, and a total of 64,035 infected by the new coronavirus, a figure much lower than São Paulo, which already has stable cases and a possible drop, and in Rio de Janeiro and Espírito Santo, which are on the rise like Minas Gerais. Large laboratories in the state of Minas Gerais point to an increase in the percentage of tests carried out mainly in the interior of the state, where only in June 60% more tests were carried out than in the previous month.
Massive tests play an important role in understanding the dynamics of virus transmission, in identifying high-risk groups and with the possibility of verifying if those analyzed have been infected or have had contact with Sars-COV-2, contributing to establish infection rates. In addition, it allows the health authorities to understand the city’s indexes and decide on the flexibility of security measures for the recovery of the economy.
RenyLab In Vitro Diagnostics is committed to the fight against coronavirus, providing products with a high quality guarantee, with a rapid test for Covid-19 with 100% accuracy (proximity between the experimentally obtained value and the true measurement value) certified by Anvisa, by FDA – Federal Agency of the United States and by the National Institute of Quality Control in Health-NIQCH.